Pub-2016

Title
Idelalisib in Waldenström macroglobulinemia: high incidence of hepatotoxicity
Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experience
Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis
Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia
Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia
Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome
Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia
Recommendations for the diagnosis and initial evaluation of patients with waldenstrom's macroglobulinaemia a task force from the 8th international workshop on waldenstrom's macroglobulinaemia
miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib
DUAL NAMPT AND BTK TARGETING LEADS TO SYNERGISTIC KILLING OF WALDENSTROM`S MACROGLOBULINEMIA CELLS REGARDLESS OF MYD88 AND CXCR4 SOMATIC MUTATIONS STATUS
Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia
To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenström Macroglobulinaemia
Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.
Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders
Atrial fibrillation associated with Ibrutinib in Waldenström's macroglobulinemia